NCT03121417View on ClinicalTrials.gov

Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

July 21, 2017

Primary Completion Date

March 9, 2019

Study Completion Date

March 9, 2019

Conditions

Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer

Interventions

BIOLOGICAL

Nivolumab

240 mg given IV

Trial Locations (2)

30308

Emory University Hospital Midtown, Atlanta

30322

Emory University/Winship Cancer Institute, Atlanta

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Emory University

OTHER